From regulatory approval, to investments, to getting coverage from insurance companies, it’s hard out there for a digital therapeutics manufacturer—but developers have found some unique pathways that work in their favor.
Industry Finds Innovative Revenue Streams For Digital Therapeutics
The digital therapeutics community has identified unique revenue streams, friendly regulations and development opportunities that have them feeling optimistic.
More from Digital Technologies
More from Medtech Insight
• By
Only 16% of venture capital general partners in Europe are women, and only 9% of those have actual investment power. Thena Capital is aiming to "redefine the image of a venture capitalist."
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Exer Labs Inc.’s website marketed its AI-based Exer Scan app to “screen and treat Parkinson’s, TB, Cerebral Palsy and more.” But those claims went well beyond what was allowed under the product’s 510(k) clearance, US regulators say.